
Inhaltsverzeichnis
Introduction. - Current Approaches To APSD Measurement of OIPs Based on Inertial Impaction. - Physical Causes of APSD Changes in Aerosols From OIPs and their Impact on Cascade Impactor Measurements. - Good Cascade Impactor Practices. - The AIM and EDA Concepts: Why they are Needed. - Product Lifecycle Approach to Cascade Impaction Measurements. - Theoretical Basis for the EDA Concept. - Performance Characterization of EDA and its Potential to Improve Decision Making in Product Batch Release. - Verification of the EDA Concept through an Assessment of Theoretical Failure Modes, Failure Mode Analysis and Case Studies with Real Data. - Validating AIM-Based Instrumentation and Associated Measurement Techniques. - The Regulatory and Compendial Acceptance Pathways for AIM and EDA. - Applying the AIM Concept in Support of Developing Improved
In Vitro
-
In Vivo
Relationships for OIPs. - Future Directions for the AIM and EDA Concepts. - Conclusions.
Es wurden noch keine Bewertungen abgegeben. Schreiben Sie die erste Bewertung zu "Good Cascade Impactor Practices, AIM and EDA for Orally Inhaled Products" und helfen Sie damit anderen bei der Kaufentscheidung.